Skip to Content

Join the 'Spritam' group to help and get support from people like you.

Spritam News

Study Sheds Light on Safety of Driving With Epilepsy

Posted 5 days ago by Drugs.com

SUNDAY, Dec. 4, 2016 – People with epilepsy who experienced longer seizures during a simulated driving test may face an increased risk for crashes while on the road, a new study suggests. About 75 percent of people with epilepsy use medication to control their seizures and are able to drive. The remainder of patients typically keep a journal of seizures, noting how long they last, and doctors use that information to determine whether patients can drive safely, the study authors explained. The new study included 16 people with epilepsy who used a driving simulator for between one to 10 hours, most for an average of three to four hours. In total, the patients had 20 seizures, seven of which resulted in "crashes." The longer the seizure, the greater the chance of a "crash." Seizures lasted an average of 75 seconds among patients who crashed and 30 seconds among those who didn't crash. The ... Read more

Related support groups: Seizures, Topamax, Epilepsy, Keppra, Tegretol, Topiramate, Dilantin, Qsymia, Carbamazepine, Seizure Prevention, Levetiracetam, Phenytoin, Tegretol XR, Valproic Acid, Seizure Prophylaxis, Keppra XR, Epitol, Carbatrol, Depakene, West Syndrome

Newer Epilepsy Drugs May Be Safer During Pregnancy

Posted 1 Sep 2016 by Drugs.com

THURSDAY, Sept. 1, 2016 – Women who take the new epilepsy drugs levetiracetam and topiramate during pregnancy don't run the risk of harming their infant's mental development, British researchers report. But the commonly prescribed anti-seizure drug valproate was linked with lower IQs in children, especially when taken at higher doses, researchers say. "The treatment of epilepsy in women who are considering a pregnancy or are pregnant involves optimizing the health of the mother as well as keeping the risk to the fetus as low as possible," said lead researcher Rebecca Bromley, a research fellow at the Institute for Human Development at the University of Manchester. In the study, children exposed to levetiracetam (Keppra) or topiramate (Topamax) in the womb did not differ from children not exposed to these drugs. And they had better outcomes than the children exposed to valproate ... Read more

Related support groups: Birth Control, Contraception, Emergency Contraception, Seizures, Topamax, Epilepsy, Keppra, Topiramate, Qsymia, Postcoital Contraception, Seizure Prevention, Levetiracetam, Vitamin/Mineral Supplementation during Pregnancy/Lactation, Keppra XR, Seizure Prophylaxis, West Syndrome, Status Epilepticus, Lennox-Gastaut Syndrome, Trokendi XR, Topamax Sprinkle

Personalized 'Pills' From a 3D Printer?

Posted 9 Nov 2015 by Drugs.com

MONDAY, Nov. 9, 2015 – With 3D printing, the concept of personalized medicine could take on a new dimension, researchers report. Mass-produced drugs can't take into account specific patient characteristics such as race, weight, and kidney and liver functions. Customized medications, on the other hand, might be more effective and less likely to cause side effects, the researchers said. For this study, investigators from Wake Forest University, Columbia University and the University of North Carolina created a prototype computer algorithm featuring software for 3D printing of personalized medications. After receiving details about a patient's specific medical and biological characteristics, the software determines personalized doses and provides data for 3D printing of medications. Five doses of 80 "pills" – ranging from 124 to 373 milligrams – were created through 3D printing, with ... Read more

Related support groups: Cardiovascular Risk Reduction, Spritam

FDA Approves Spritam (levetiracetam) as the First 3D Printed Drug Product

Posted 4 Aug 2015 by Drugs.com

BLUE ASH, Ohio, August 3, 2015 – Aprecia Pharmaceuticals Company today announced that the U.S. Food and Drug Administration (FDA) has approved Spritam (levetiracetam) for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy.1 Spritam utilizes Aprecia's proprietary ZipDose® Technology platform, a groundbreaking advance that uses three-dimensional printing (3DP) to produce a porous formulation that rapidly disintegrates with a sip of liquid.1 While 3DP has been used previously to manufacture medical devices, this approval marks the first time a drug product manufactured with this technology has been approved by the FDA. “By combining 3DP technology with a highly-prescribed epilepsy treatment,2 Spritam is designed to fill a need for patients who st ... Read more

Related support groups: Seizures, Epilepsy, Levetiracetam, Spritam

FDA Approves First Pill Made by 3D Printing

Posted 4 Aug 2015 by Drugs.com

TUESDAY, Aug. 4, 2015 – The age of 3D printing has come to the drug industry, with the U.S. Food and Drug Administration on Monday approving the first pill made with the technology. The agency approved the prescription drug Spritam (levetiracetam) as a 3D-printed pill, to be taken with other medicines for seizures in certain children and adults with epilepsy. According to a news release from Ohio-based Aprecia Pharmaceuticals, the drug is made using a 3D printing method called ZipDose Technology, which produces a porous pill that rapidly disintegrates with a sip of liquid. 3D printing has already been used to make medical devices, but Spritam is the first 3D-printed drug to be approved for sale in the United States. It is expected to be available early next year. Experts say 3D printing of pills could usher in an era where drugs can be custom-ordered, based on specific patient needs, ... Read more

Related support groups: Seizures, Keppra, Seizure Prevention, Levetiracetam, Seizure Prophylaxis, Keppra XR, Spritam, Elepsia XR

Ask a Question

Further Information

Related Condition Support Groups

Seizures, Epilepsy

Spritam Patient Information at Drugs.com